PeriFRL Monitor
Circulatory Dysfunction / Peripheral Perfusion Assessment
Pre-clinicalActive
Key Facts
Indication
Circulatory Dysfunction / Peripheral Perfusion Assessment
Phase
Pre-clinical
Status
Active
Company
About ProMedix
ProMedix is a private, clinical-stage diagnostics company developing the PeriFRL, a noninvasive, Bluetooth-connected monitor that digitizes the measurement of capillary refill time (CRT) to assess peripheral perfusion. The technology addresses the unreliability of subjective CRT assessment and targets critical conditions like sepsis, shock, and hemorrhage, with initial validation from over 2,000 patient encounters under IRB protocols. Backed by industrial and institutional partners, the company is positioning its affordable, easy-to-use device for use in hospitals, home health, and pre-hospital settings, aligning with clinical guidelines that recommend CRT for resuscitation guidance.
View full company profile